Back to Search Start Over

The association between distal symmetric polyneuropathy in diabetes with all-cause mortality - a meta-analysis.

Authors :
Vági OE
Svébis MM
Domján BA
Körei AE
Tesfaye S
Horváth VJ
Kempler P
Tabák ÁG
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Feb 16; Vol. 14, pp. 1079009. Date of Electronic Publication: 2023 Feb 16 (Print Publication: 2023).
Publication Year :
2023

Abstract

Background: Distal symmetric polyneuropathy (DSPN) is a common microvascular complication of both type 1 and 2 diabetes with substantial morbidity burden and reduced quality of life. Its association with mortality is equivocal.<br />Purpose: To describe the association between DSPN and all-cause mortality in people with diabetes and further stratify by the type of diabetes based on a meta-analysis of published observational studies.<br />Data Sources: We searched Medline from inception to May 2021.<br />Study Selection: Original data were collected from case-control and cohort studies that reported on diabetes and DSPN status at baseline and all-cause mortality during follow-up.<br />Data Extraction: was completed by diabetes specialists with clinical experience in neuropathy assessment.<br />Data Synthesis: Data was synthesized using random-effects meta-analysis. The difference between type 1 and 2 diabetes was investigated using meta-regression.<br />Results: A total of 31 cohorts (n=155,934 participants, median 27.4% with DSPN at baseline, all-cause mortality 12.3%) were included. Diabetes patients with DSPN had an almost twofold mortality (HR: 1.96, 95%CI: 1.68-2.27, I2 = 91.7%), I <superscript>2 =</superscript> 91.7%) compared to those without DSPN that was partly explained by baseline risk factors (adjusted HR: 1.60, 95%CI: 1.37-1.87, I <superscript>2 =</superscript> 78.86%). The association was stronger in type 1 compared to type 2 diabetes (HR: 2.22, 95%CI: 1.43-3.45). Findings were robust in sensitivity analyses without significant publication bias.<br />Limitations: Not all papers reported multiple adjusted estimates. The definition of DSPN was heterogeneous.<br />Conclusions: DSPN is associated with an almost twofold risk of death. If this association is causal, targeted therapy for DSPN could improve life expectancy of diabetic patients.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer VS declared a past co-authorship with the authors ST, PK to the handling editor.<br /> (Copyright © 2023 Vági, Svébis, Domján, Körei, Tesfaye, Horváth, Kempler and Tabák.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Report
Accession number :
36875485
Full Text :
https://doi.org/10.3389/fendo.2023.1079009